These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18922828)

  • 1. Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials.
    O'Neil BH; Goldberg RM
    Oncologist; 2008 Oct; 13(10):1074-83. PubMed ID: 18922828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on treatment advances for the first-line therapy of metastatic colorectal cancer.
    Lee JJ; Chu E
    Cancer J; 2007; 13(5):276-81. PubMed ID: 17921724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Third-line therapy for metastatic colorectal cancer.
    Gundgaard MG; Soerensen JB; Ehrnrooth E
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):1-13. PubMed ID: 17786445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent progress in the treatment of colorectal cancer].
    Thuss-Patience PC; Reichardt P; Riess H; Kretzschmar A
    Med Klin (Munich); 2006 Feb; 101(2):114-9. PubMed ID: 16501908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal treatment of metastatic colorectal cancer.
    Pessino A; Sobrero A
    Expert Rev Anticancer Ther; 2006 May; 6(5):801-12. PubMed ID: 16759170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic colorectal cancer: first- and second-line treatment in 2005.
    Rougier P; Lepère C
    Semin Oncol; 2005 Dec; 32(6 Suppl 8):15-20. PubMed ID: 16360007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapy for metastatic colorectal cancer].
    Iwasa S; Shimada Y
    Gan To Kagaku Ryoho; 2008 Sep; 35(9):1467-74. PubMed ID: 18799899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimum use of biologics and role of maintenance therapy in colon cancer.
    Marshall J
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S33-5. PubMed ID: 17178283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
    Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
    Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive chemotherapy of metastatic colorectal cancer: weighing between safety and clinical efficacy: Evaluation of Masi G, Loupakis F, Salvatore L, et al. Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial. Lancet Oncol 2010;11:845-52.
    Bruera G; Ricevuto E
    Expert Opin Biol Ther; 2011 Jun; 11(6):821-4. PubMed ID: 21545334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients.
    Sorbye H; Pfeiffer P; Cavalli-Björkman N; Qvortrup C; Holsen MH; Wentzel-Larsen T; Glimelius B
    Cancer; 2009 Oct; 115(20):4679-87. PubMed ID: 19562777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent therapy in the palliative treatment of metastatic colorectal cancer.
    Wadhawan A; Stephens R; Adams R
    Expert Rev Anticancer Ther; 2009 Jan; 9(1):125-34. PubMed ID: 19105712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
    Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
    Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surrogate end points for median overall survival in metastatic colorectal cancer: literature-based analysis from 39 randomized controlled trials of first-line chemotherapy.
    Tang PA; Bentzen SM; Chen EX; Siu LL
    J Clin Oncol; 2007 Oct; 25(29):4562-8. PubMed ID: 17876010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The continuum of care: a paradigm for the management of metastatic colorectal cancer.
    Goldberg RM; Rothenberg ML; Van Cutsem E; Benson AB; Blanke CD; Diasio RB; Grothey A; Lenz HJ; Meropol NJ; Ramanathan RK; Becerra CH; Wickham R; Armstrong D; Viele C
    Oncologist; 2007 Jan; 12(1):38-50. PubMed ID: 17227899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential versus combination therapy in the treatment of patients with advanced colorectal cancer.
    Shah U; Goldberg RM
    Clin Colorectal Cancer; 2008 Sep; 7(5):315-20. PubMed ID: 18794063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between progression free survival and response rate in patients with metastatic colorectal carcinoma.
    Louvet C; de Gramont A; Tournigand C; Artru P; Maindrault-Goebel F; Krulik M
    Cancer; 2001 Jun; 91(11):2033-8. PubMed ID: 11391582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of UFT in metastatic colorectal cancer.
    Bennouna J; Saunders M; Douillard JY
    Oncology; 2009; 76(5):301-10. PubMed ID: 19299903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic colorectal cancer: recent advances in its clinical management.
    Barugel ME; Vargas C; Krygier Waltier G
    Expert Rev Anticancer Ther; 2009 Dec; 9(12):1829-47. PubMed ID: 19954294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted therapy for metastatic colorectal cancer: role of aflibercept.
    Mitchell EP
    Clin Colorectal Cancer; 2013 Jun; 12(2):73-85. PubMed ID: 23102896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.